Clinical Trial Update: Granulocyte Colony Stimulating Factor (G-CSF) After Salvage Chemotherapy in Refractory AML [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update discusses the use of granulocyte colony stimulating factor (G-CSF) after salvage chemotherapy in patients with refractory acute myelo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Filgrastim (filgrastim)

Snippet

Sponsor: Seoul St. Mary's Hospital | Conditions: Leukemia, Myeloid, Acute | Phase 2, Phase 3 | Status: UNKNOWN